These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9795529

  • 1. Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A.
    Wu SL, Chang TC, Huang CN, Chuang LM, Chang TJ.
    J Formos Med Assoc; 1998 Sep; 97(9):614-8. PubMed ID: 9795529
    [Abstract] [Full Text] [Related]

  • 2. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 Sep; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
    Sánchez B, Robledo M, Biarnes J, Sáez ME, Volpini V, Benítez J, Navarro E, Ruiz A, Antiñolo G, Borrego S.
    J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371
    [Abstract] [Full Text] [Related]

  • 4. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.
    Padberg BC, Schröder S, Jochum W, Kastendieck H, Roth J, Heitz PU, Komminoth P.
    Am J Pathol; 1995 Dec; 147(6):1600-7. PubMed ID: 7495285
    [Abstract] [Full Text] [Related]

  • 5. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
    Chung YJ, Kim HH, Kim HJ, Min YK, Lee MS, Lee MK, Kim KW, Ki CS, Kim JW, Chung JH.
    Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
    [Abstract] [Full Text] [Related]

  • 6. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G, Domené HM, Iorcansky S, Barontini M.
    Medicina (B Aires); 1998 Oct; 58(2):179-84. PubMed ID: 9706252
    [Abstract] [Full Text] [Related]

  • 7. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
    Maruyama S, Iwashita T, Imai T, Funahashi H, Ceccherini I, Luo Y, Romeo G, Matsuo S, Matsuyama M, Takahashi M.
    Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
    Huang CN, Wu SL, Chang TC, Huang SH, Chang TJ.
    J Formos Med Assoc; 1998 Aug; 97(8):541-6. PubMed ID: 9747064
    [Abstract] [Full Text] [Related]

  • 10. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas.
    Chew SL, Lavender P, Jain A, Weber A, Ross RJ, Wass JA, Besser GM, Clark AJ.
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):17-21. PubMed ID: 7889627
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.
    Borst MJ, VanCamp JM, Peacock ML, Decker RA.
    Surgery; 1995 Apr; 117(4):386-91. PubMed ID: 7716719
    [Abstract] [Full Text] [Related]

  • 12. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
    Wohllk N, Becker P, Youlton R, Cote GJ, Gagel RF.
    Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
    [Abstract] [Full Text] [Related]

  • 13. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 14. Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene.
    Tsai MS, Ledger GA, Khosla S, Gharib H, Thibodeau SN.
    J Clin Endocrinol Metab; 1994 May 15; 78(5):1261-4. PubMed ID: 7909818
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E, Russo D, Giuffrida D, Zampa GA, Meringolo D, Arturi F, Chiodini I, Bianchi D, Attard M, Trischitta V, Bruno R, Giannasio P, Pontecorvi A, Filetti S.
    J Endocrinol Invest; 1998 Jun 15; 21(6):358-64. PubMed ID: 9699127
    [Abstract] [Full Text] [Related]

  • 19. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, Raue F, Ritter MM, Höppner W.
    J Clin Endocrinol Metab; 1998 Mar 15; 83(3):770-4. PubMed ID: 9506724
    [Abstract] [Full Text] [Related]

  • 20. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M, Weinhüsel A, Niederle B, Haas OA.
    Int J Cancer; 1996 Aug 22; 69(4):312-6. PubMed ID: 8797874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.